课题基金 / 基金详情

Three-dimensional imaging of cells and tissues for the clarification of pathogenesis of inherited metabolic diseases.

Three-dimensional imaging of cells and tissues for the clarification of pathogenesis of inherited metabolic diseases.
细胞和组织的三维成像,用于阐明遗传性​​代谢疾病的发病机制。
批准号:
06670847
负责人:
SAKURABA Hitoshi
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SAKURABA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The basic understanding of sphingolipidosis requires study of the clinical, biochemical, and pathological aspects. To study the pathological aspects, the organs and tissues affected by the disease must be observed. We have used volume visualization techniques to create three-dimensional (3D) images of a brain affected by late infantile metachromatic leukodystrophy (MLD) and of a biopsied kidney tissue affected by Fabry disease.The 3D brain images of a MLD patient showed clearly, stereographically, and non-invasively the intracerebral lesion. This lesion, which indicated hyperintensity in magnetic resonance (MR) images, extended throughout the periventricular white matter. The 3D brain images provided to integrate information in combination with two-dimensional MR images. Volumetric ray-casting was useful in obtaining directly images of the entire brain and in allowing an intuitive understanding of the extension of the lesion in three dimensions and of the extent of the defects in the MLD brain. Isosurfacing facilitated a clear extraction of the lesion located by volumetric ray-casting. Each technique used in this study playd a role in visualization and their use was complementary.The combination of a laser scanning confocal microscopic analysis and the volume visualization showed stereographically the accumulation of globotriaosylceramide in the biopsied kidney tissue from a patient with Fabry disease.3D images will promote basic and clinical investigations of sphingolipidosis.
期刊论文(107)
专著(0)
科研奖励(0)
会议论文
Kuroki, Y.: "A nobel missense mutation(C552Y) is present in the β-hexosaminidase β-subunit gene of a Japanese patient with infantile Sandhoff disease." Biochem. Biophys. Res. Commun.212. 564-571 (1995)
Kuroki, Y.:“患有婴儿桑霍夫病的日本患者的 β-己糖胺酶 β 亚基基因中存在诺贝尔错义突变 (C552Y)。Biochem。212。Commun。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takenaka, T.: "Coexistence of gene mutations causing Fabry Disease and Duchenne muscular dystrophy in a Japanese boy." Clin. Genet.(in press).
Takenaka, T.:“导致日本男孩法布里病和杜氏肌营养不良症的基因突变共存。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishii, N., et al.: "Normal serum beta-galactosidase in juvenile GM1 gangliosidosis." Pediatr.Neurol.10. 317-319 (1994)
Ishii, N. 等人:“幼年 GM1 神经节苷脂沉积症中的正常血清 β-半乳糖苷酶。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itoh, K., et al.: "Immunofluorescence analysis of globotriaosylceramide accumulated in the hearts of variant hemizygotes and heterzygotes with Fabry disease." Am.J.Cardiol. (in press).
Itoh, K. 等人:“对患有法布里病的变异半合子和杂合子心脏中积累的三酰神经酰胺进行免疫荧光分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
51
    Development of a new biomarker of GM2 gangliosidosis
    • 批准号:
      23659527
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2011
    • 负责人:
      SAKURABA Hitoshi
    • 依托单位:
    Thermodynamic and structural study on the interaction of an enzyme and a substrate analogue for development of new therapy for lysosomal diseases
    • 批准号:
      21390314
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2009
    • 负责人:
      SAKURABA Hitoshi
    • 依托单位:
    Structure-based modification of lysosomal enzymes: development of new enzyme replacement therapy for lysosomal diseases
    Development of enzyme replacement therapy for lysosomal diseases using yeast expression system.
    海外基金